1. Home
  2. BDTX vs FLL Comparison

BDTX vs FLL Comparison

Compare BDTX & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • FLL
  • Stock Information
  • Founded
  • BDTX 2014
  • FLL 1987
  • Country
  • BDTX United States
  • FLL United States
  • Employees
  • BDTX N/A
  • FLL N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • FLL Hotels/Resorts
  • Sector
  • BDTX Health Care
  • FLL Consumer Discretionary
  • Exchange
  • BDTX Nasdaq
  • FLL Nasdaq
  • Market Cap
  • BDTX 161.6M
  • FLL 157.3M
  • IPO Year
  • BDTX 2020
  • FLL 1993
  • Fundamental
  • Price
  • BDTX $2.62
  • FLL $4.54
  • Analyst Decision
  • BDTX Strong Buy
  • FLL Buy
  • Analyst Count
  • BDTX 4
  • FLL 3
  • Target Price
  • BDTX $15.50
  • FLL $6.67
  • AVG Volume (30 Days)
  • BDTX 591.8K
  • FLL 120.6K
  • Earning Date
  • BDTX 11-05-2024
  • FLL 11-06-2024
  • Dividend Yield
  • BDTX N/A
  • FLL N/A
  • EPS Growth
  • BDTX N/A
  • FLL N/A
  • EPS
  • BDTX N/A
  • FLL N/A
  • Revenue
  • BDTX N/A
  • FLL $279,132,000.00
  • Revenue This Year
  • BDTX N/A
  • FLL $24.43
  • Revenue Next Year
  • BDTX N/A
  • FLL $12.32
  • P/E Ratio
  • BDTX N/A
  • FLL N/A
  • Revenue Growth
  • BDTX N/A
  • FLL 28.57
  • 52 Week Low
  • BDTX $2.09
  • FLL $4.42
  • 52 Week High
  • BDTX $7.66
  • FLL $5.98
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 31.71
  • FLL 32.95
  • Support Level
  • BDTX $3.16
  • FLL $4.81
  • Resistance Level
  • BDTX $3.44
  • FLL $5.10
  • Average True Range (ATR)
  • BDTX 0.22
  • FLL 0.26
  • MACD
  • BDTX 0.03
  • FLL -0.06
  • Stochastic Oscillator
  • BDTX 0.61
  • FLL 2.04

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About FLL Full House Resorts Inc.

Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.

Share on Social Networks: